WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2025

Feb 20, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2025-02-18

Reporting Person: Green Eric Mark (Director, President, CEO and Board Chair)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-18	Common Stock	M	2460.991	$211.00	Acquired	170369.1155	Direct
2025-02-18	Common Stock	F	700.296	$211.00	Disposed	169668.8195	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-18	Stock Option (Right to Buy)	$211.00	A	12149	Acquired	2035-02-18	Common Stock (12149)	Direct
2025-02-18	Rst. Stock Unit	$0	A	5256	Acquired		Common Stock (5256)	Direct

Footnotes

F1: This award vests in four equal installments beginning on February 18, 2026.